Characterization ofBRCA1andBRCA2deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study
Open Access
- 26 January 2010
- journal article
- mutation in-brief
- Published by Hindawi Limited in Human Mutation
- Vol. 31 (3), E1200-E1240
- https://doi.org/10.1002/humu.21202
Abstract
BRCA1 and BRCA2 screening in women at high‐risk of breast cancer results in the identification of both unambiguously defined deleterious mutations and sequence variants of unknown clinical significance (VUS). We examined a population‐based sample of young women with contralateral breast cancer (CBC, n=705) or unilateral breast cancer (UBC, n=1398). We identified 470 unique sequence variants, of which 113 were deleterious mutations. The remaining 357 VUS comprised 185 unique missense changes, 60% were observed only once, while 3% occurred with a frequency of >10%. Deleterious mutations occurred three times more often in women with CBC (15.3%) than in women with UBC (5.2%), whereas combined, VUS were observed in similar frequencies in women with CBC and UBC. A protein alignment algorithm defined 16 rare VUS, occurring at highly conserved residues and/or conferring a considerable biochemical difference, the majority located in the BRCA2 DNA‐binding domain. We confirm a multiplicity of BRCA1 and BRCA2 VUS that occur at a wide range of allele frequencies. Although some VUS inflict chemical differences at conserved residues, suggesting a deleterious effect, the majority are not associated with an increased risk of CBC.This publication has 36 references indexed in Scilit:
- Application of Embryonic Lethal or Other Obvious Phenotypes to Characterize the Clinical Significance of Genetic Variants Found in Trans with Known Deleterious MutationsCancer Research, 2005
- Does nonsense-mediated mRNA decay explain the ovarian cancer cluster region of the BRCA2 gene?Oncogene, 2005
- Nonsense-mediated mRNA decay: molecular insights and mechanistic variations across speciesCurrent Opinion in Cell Biology, 2005
- Functional Evaluation and Cancer Risk Assessment of BRCA2 Unclassified VariantsCancer Research, 2005
- Integrated Evaluation of DNA Sequence Variants of Unknown Clinical Significance: Application to BRCA1 and BRCA2American Journal of Human Genetics, 2004
- Characterization of single-nucleotide polymorphisms in coding regions of human genesNature Genetics, 1999
- The BRC repeats are conserved in mammalian BRCA2 proteinsHuman Molecular Genetics, 1997
- Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 geneNature Genetics, 1997
- A polymorphic stop codon in BRCA2Nature Genetics, 1996
- Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype–phenotype correlationNature Genetics, 1995